Aytu Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Aytu BioScience
AYTU Stock  USD 1.23  0.03  2.50%   
Aytu BioScience financial statements provide useful quarterly and yearly information to potential Aytu BioScience investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aytu BioScience financial statements helps investors assess Aytu BioScience's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aytu BioScience's valuation are summarized below:
Gross Profit
50.4 M
Profit Margin
(0.07)
Market Capitalization
7.4 M
Enterprise Value Revenue
0.0374
Revenue
77.2 M
There are currently one hundred twenty fundamental signals for Aytu BioScience that can be evaluated and compared over time across rivals. All traders should validate Aytu BioScience's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 22.6 M in 2025, whereas Market Cap is likely to drop slightly above 17.8 M in 2025.

Aytu BioScience Total Revenue

97.81 Million

Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10 M, Interest Expense of 5.2 M or Selling General Administrative of 27.2 M, as well as many indicators such as Price To Sales Ratio of 289, Dividend Yield of 0.0 or PTB Ratio of 3.5. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
  
Check out the analysis of Aytu BioScience Correlation against competitors.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Aytu BioScience Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets142.6 M135.8 M75.9 M
Slightly volatile
Short and Long Term Debt Total18.3 M17.4 M12.1 M
Slightly volatile
Other Current Liabilities57.4 M54.7 M18.8 M
Slightly volatile
Total Current Liabilities75.1 M71.6 M31.9 M
Slightly volatile
Property Plant And Equipment Net1.4 M1.8 M1.6 M
Slightly volatile
Accounts Payable12.6 M12 M6.4 M
Slightly volatile
Cash12 M23 M14.5 M
Slightly volatile
Non Current Assets Total67.9 M64.6 M40.3 M
Slightly volatile
Cash And Short Term Investments12.1 M23 M14.6 M
Slightly volatile
Common Stock Shares Outstanding6.7 M6.4 M1.5 M
Slightly volatile
Liabilities And Stockholders Equity142.6 M135.8 M75.9 M
Slightly volatile
Non Current Liabilities Total34 M32.4 M14.9 M
Slightly volatile
Total Liabilities109.1 M103.9 M46.8 M
Slightly volatile
Property Plant And Equipment Gross4.4 M4.2 M2.1 M
Slightly volatile
Total Current Assets74.7 M71.2 M35.6 M
Slightly volatile
Short Term Debt3.6 M4.9 M3.9 M
Pretty Stable
Common Stock Total Equity2.6 K2.7 K66.7 K
Slightly volatile
Other Current Assets6.8 M6.5 M2.9 M
Slightly volatile
Common Stock85590066.3 K
Slightly volatile
Current Deferred Revenue27.6 M44.4 M17.2 M
Slightly volatile
Capital Surpluse259.6 M247.3 M124.7 M
Slightly volatile
Intangible Assets35.8 M60.3 M30.5 M
Slightly volatile
Property Plant Equipment4.7 M4.4 M2.1 M
Slightly volatile
Other Liabilities12.2 M15.4 M9.6 M
Slightly volatile
Other Assets956.3 K910.8 K444.4 K
Slightly volatile
Net Receivables28.5 M27.2 M10.4 M
Slightly volatile
Inventory15.3 M14.5 M6 M
Slightly volatile
Deferred Long Term Liabilities9.7 K10.2 K129.8 K
Slightly volatile
Non Current Liabilities Other4.9 M5.2 M6.9 M
Slightly volatile
Long Term Debt9.4 M12.5 M6.8 M
Slightly volatile
Short and Long Term Debt5.5 M3.8 M5.1 M
Very volatile
Net Invested Capital61.4 M49.3 M36.3 M
Slightly volatile
Preferred Stock Total Equity287323352
Slightly volatile
Capital Stock8559002.6 K
Very volatile
Long Term Debt Total8.9 M10.1 M11 M
Slightly volatile
Capital Lease Obligations2.5 M4.1 M1.9 M
Slightly volatile

Aytu BioScience Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10 M9.5 M4.5 M
Slightly volatile
Selling General Administrative27.2 M25.9 M15.7 M
Slightly volatile
Other Operating Expenses104.2 M99.2 M49.6 M
Slightly volatile
Total Operating Expenses73.1 M69.7 M35.7 M
Slightly volatile
Total Revenue97.8 M93.2 M36.6 M
Slightly volatile
Gross Profit65.9 M62.8 M22.6 M
Slightly volatile
Research Development4.3 M3.2 M3.8 M
Pretty Stable
Interest Income388.8 K409.2 K1 M
Very volatile
Non Recurring167 K175.8 K3.1 M
Slightly volatile
Selling And Marketing Expenses27.3 M31 M14.4 M
Slightly volatile
Reconciled Depreciation6.7 M9.5 M5.7 M
Slightly volatile

Aytu BioScience Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow27.8 M26.4 M14.7 M
Slightly volatile
Depreciation10 M9.5 M4.6 M
Slightly volatile
End Period Cash Flow12.1 M23 M14.6 M
Slightly volatile
Stock Based Compensation2.2 M3.3 M2 M
Slightly volatile
Dividends Paid22 K24.7 K27 K
Slightly volatile
Issuance Of Capital Stock3 M3.1 M17.8 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio289304112
Pretty Stable
PTB Ratio3.53.3362.1109
Slightly volatile
Days Sales Outstanding106122129
Slightly volatile
Book Value Per Share626.4 K596.6 K456.4 K
Slightly volatile
Average Payables5.4 K5.7 K805.1 K
Slightly volatile
Stock Based Compensation To Revenue8.068.48482.3495
Very volatile
Capex To Depreciation0.10.111.0334
Slightly volatile
PB Ratio3.53.3362.1109
Slightly volatile
Inventory Turnover1.661.882.0775
Very volatile
Days Of Inventory On Hand242201206
Very volatile
Sales General And Administrative To Revenue41.8139.820111.3607
Very volatile
Average Inventory4.5 K4.7 K4.1 M
Very volatile
Research And Ddevelopement To Revenue65.4468.88312.6931
Slightly volatile
Capex To Revenue0.170.180.3896
Slightly volatile
Cash Per Share308 K293.3 K228.4 K
Slightly volatile
Income Quality0.780.98620.7692
Pretty Stable
Intangibles To Total Assets0.650.68240.5554
Very volatile
Current Ratio0.970.5422.6833
Slightly volatile
Receivables Turnover5.823.944.333
Pretty Stable
Shareholders Equity Per Share626.4 K596.6 K456.4 K
Slightly volatile
Debt To Equity0.90.85670.2206
Slightly volatile
Capex Per Share1.1 K1.2 K39.2 K
Slightly volatile
Average Receivables3.5 M3.3 M1.8 M
Slightly volatile
Revenue Per Share6.2 K6.5 K15.8 K
Slightly volatile
Interest Debt Per Share542 K516.2 K85.9 K
Slightly volatile
Debt To Assets0.360.38280.0851
Slightly volatile
Operating Cycle348323335
Slightly volatile
Price Book Value Ratio3.53.3362.1109
Slightly volatile
Company Equity Multiplier1.422.23792.2737
Slightly volatile
Long Term Debt To Capitalization0.160.250.0887
Slightly volatile
Total Debt To Capitalization0.480.46140.1406
Slightly volatile
Debt Equity Ratio0.90.85670.2206
Slightly volatile
Quick Ratio0.870.54032.5357
Slightly volatile
Net Income Per E B T1.210.87271.1961
Very volatile
Cash Ratio0.680.43332.1387
Slightly volatile
Days Of Inventory Outstanding242201206
Very volatile
Days Of Sales Outstanding106122129
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.211.151.1144
Slightly volatile
Price To Book Ratio3.53.3362.1109
Slightly volatile
Fixed Asset Turnover0.981.033815.573
Slightly volatile
Debt Ratio0.360.38280.0851
Slightly volatile
Price Sales Ratio289304112
Pretty Stable
Asset Turnover0.00470.00490.2118
Slightly volatile
Gross Profit Margin30.028.57144.2013
Slightly volatile
Price Fair Value3.53.3362.1109
Slightly volatile

Aytu BioScience Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap17.8 M17.9 M29.5 M
Slightly volatile
Enterprise Value22.6 M19.9 M24.9 M
Slightly volatile

Aytu Fundamental Market Drivers

Forward Price Earnings0.8795
Cash And Short Term Investments20 M

Aytu Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Aytu BioScience Financial Statements

Aytu BioScience shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue44.4 M27.6 M
Total Revenue93.2 M97.8 M
Cost Of Revenue30.4 M15.4 M
Stock Based Compensation To Revenue 8.48  8.06 
Sales General And Administrative To Revenue 39.82  41.81 
Research And Ddevelopement To Revenue 68.88  65.44 
Capex To Revenue 0.18  0.17 
Revenue Per Share6.5 K6.2 K
Ebit Per Revenue(107.70)(102.32)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY